Development Partnership with CelVida Yields First Milestone
NEW YORK, May 13 /PRNewswire-FirstCall/ -- NeoStem, Inc. (Amex: NBS),
which is pioneering the pre-disease collection, processing and long-term
storage of adult stem cells for future medical need, today announced that a
site has been secured for a new stem cell collection center in Coral
Gables, Florida, a suburb of Miami.
Robin Smith, MD MBA, NeoStem's Chairman and Chief Executive Officer
commented: "Securing the Florida site for a new collection center in our
network is the first major step in building a presence in the Southeast
region of the country. Florida is a significant healthcare market offering
a dynamic population of both the young and the aging. We are focused on
expanding NeoStem's national network of collection centers in major
metropolitan areas of the US to drive growth and revenues."
The Florida site is the result of a development agreement with CelVida
LLC to join NeoStem's growing national network. CelVida develops and
operates stem cell collection centers and related activities, including
using NeoStem's proprietary, minimally invasive process.
Chester Amedia, Jr. MD, FACP, founder and President of CelVida LLC, is
an interventional nephrologist with extensive business and patient care
experience in the fields of disease management and extracorporeal
therapies. Dr. Amedia holds the academic rank of Clinical Professor of
Internal Medicine at Northeastern Ohio Universities College of Medicine,
where he is active in the teaching of medical students. He is a diplomat of
the American Board of Internal Medicine with subspecialty certification in
nephrology, has been a co-investigator or local coordinator for a number of
multicenter research projects, and is a Fellow of the American College of
Physicians.
"We are pleased and excited to bring NeoStem to the Miami area to give
people the opportunity to proactively have their stem cells collected for
preservation and future use," said Dr. Amedia. "CelVida believes this
collaboration with NeoStem will provide forward thinking, healthy people in
the southeastern United States the opportunity to secure bio-insurance for
their medical futures."
About NeoStem, Inc.
NeoStem has a growing nationwide network of adult stem cell collection
centers, enabling people to donate and store their own (autologous) stem
cells when they are young and healthy for their personal use in times of
future medical need. The Company has also recently entered into research
and development through the acquisition of a worldwide exclusive license to
technology to identify and isolate VSELs (very small embryonic-like stem
cells), which have been shown to have several physical characteristics that
are generally found in embryonic stem cells.
Forward-Looking Statements
This press release contains forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements reflect management's current expectations, as of
the date of this press release, and involve certain risks and
uncertainties. The Company's actual results could differ materially from
those anticipated in these forward-looking statements as a result of
various factors. Factors that could cause future results to materially
differ from the recent results or those projected in forward-looking
statements include the "Risk Factors" described in the Company's periodic
filings with the Securities and Exchange Commission.
Contact:
NeoStem, Inc.
Robin Smith, Chief Executive Officer
T: 212-584-4180
E: rsmith@neostem.com
http://www.neostem.com
SOURCE NeoStem, Inc.
 back to top
Related links:
http://www.neostem.com
CONTACT:
Robin Smith, Chief Executive Officer of
NeoStem, Inc., +1-212-584-4180, rsmith@neostem.com
|
